Jessica G. Gardiner, Susan M. Colegrove, Jorge L. Castillo Gonzalez, M. Naylor, Roberto Lopez-Tamayo
{"title":"10.1在护理、儿童和青少年人群中,使用二甲双胍减轻与第二代抗精神病药使用相关的BMI变化","authors":"Jessica G. Gardiner, Susan M. Colegrove, Jorge L. Castillo Gonzalez, M. Naylor, Roberto Lopez-Tamayo","doi":"10.1016/j.jaac.2021.09.130","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":17190,"journal":{"name":"Journal of the American Academy of Child & Adolescent Psychiatry","volume":"49 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2021-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"10.1 Use of Metformin to Attenuate BMI Changes Associated With Second-Generation Antipsychotic Use in the Youth in the Care, Child, and Adolescent Population\",\"authors\":\"Jessica G. Gardiner, Susan M. Colegrove, Jorge L. Castillo Gonzalez, M. Naylor, Roberto Lopez-Tamayo\",\"doi\":\"10.1016/j.jaac.2021.09.130\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":17190,\"journal\":{\"name\":\"Journal of the American Academy of Child & Adolescent Psychiatry\",\"volume\":\"49 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-10-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of the American Academy of Child & Adolescent Psychiatry\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1016/j.jaac.2021.09.130\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of the American Academy of Child & Adolescent Psychiatry","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/j.jaac.2021.09.130","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
10.1 Use of Metformin to Attenuate BMI Changes Associated With Second-Generation Antipsychotic Use in the Youth in the Care, Child, and Adolescent Population